Aardvark Therapeutics (NASDAQ: AARD)
$11.13
(-7.9%)
-$0.95
Price as of June 20, 2025, 4:00 p.m. ET
Aardvark Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Aardvark Therapeutics Company Info
Aardvark Therapeutics specializes in small molecule therapeutics for obesity and rare genetic metabolic disorders. Aardvark Therapeutics was founded by Tien Lee in 2017.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.